首页 › 基金 › ARMISTICE CAPITAL, LLC › ANRO
ARMISTICE CAPITAL, LLC 对 ANRO 的持仓历史
ALTO NEUROSCIENCE INC COM SHS · 医疗保健
ARMISTICE CAPITAL, LLC 在 Q2 2026 的 13F 申报中披露持有 ANRO(ALTO NEUROSCIENCE INC COM SHS)864,000 股,市值约 US$22.8M,约占其申报组合的 0.30%,在其申报持仓中市值排名第 49 位。 ARMISTICE CAPITAL, LLC 最近 7 个申报季度中有 7 个季度披露了 ANRO 持仓,最早可追溯至 Q4 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
ARMISTICE CAPITAL, LLC 对 ANRO 的持仓演变
ARMISTICE CAPITAL, LLC 于 Q4 2024 首次披露 ANRO 持仓:650,000 股(约 US$2.7M)。 该持仓在 Q4 2025 达到峰值 1,536,000 股,市值约 US$27.3M。 在 7 次申报中,ARMISTICE CAPITAL, LLC 3 次增持、3 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 864,000 股、市值约 US$22.8M,环比减持 -48,000 股。。 持仓曾出现大幅变动:Q1 2025 增持约 146% (随后一个季度股价上涨 2%)、Q1 2026 减持约 41% (随后一个季度股价上涨 17%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2024 | 650.00K | $2.75M | 新进 |
| Q1 2025 | 1.60M | $3.46M | 增持 |
| Q2 2025 | 1.62M | $3.57M | 增持 |
| Q3 2025 | 1.64M | $6.58M | 增持 |
| Q4 2025 | 1.54M | $27.34M | 减持 |
| Q1 2026 | 912.00K | $20.50M | 减持 |
| Q2 2026 | 864.00K | $22.80M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANRO 与 13F 数据
ANRO(ALTO NEUROSCIENCE INC COM SHS)属于医疗保健行业。我们追踪的基金中还有 58 只申报持有 ANRO,申报仓位最大的包括:Alpha Wave Global, LP (US$97.8M), Commodore Capital LP (US$71.9M), PERCEPTIVE ADVISORS LLC (US$42.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANRO 的基金
- Alpha Wave Global, LP 3.71M 股 · $97.85M · Q2 2026
- Commodore Capital LP 2.72M 股 · $71.87M · Q2 2026
- PERCEPTIVE ADVISORS LLC 1.61M 股 · $42.49M · Q2 2026
- Spruce Street Capital LP 1.35M 股 · $35.71M · Q2 2026
- Vivo Capital, LLC 1.21M 股 · $31.90M · Q2 2026
- Affinity Asset Advisors, LLC 850.00K 股 · $22.43M · Q2 2026
- Vestal Point Capital, LP 785.00K 股 · $20.72M · Q2 2026
- 72 Investment Holdings, LLC 667.78K 股 · $17.62M · Q2 2026
- Venrock Adviser, LLC 500.00K 股 · $13.20M · Q2 2026
- Parkman Healthcare Partners LLC 429.04K 股 · $11.32M · Q2 2026
- Ikarian Capital, LLC 407.34K 股 · $10.75M · Q2 2026
- Saturn V Capital Management LP 182.83K 股 · $4.82M · Q2 2026
更多关于 ARMISTICE CAPITAL, LLC
常见问题
How long has ARMISTICE CAPITAL, LLC held ANRO?
ARMISTICE CAPITAL, LLC has disclosed ANRO holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is ARMISTICE CAPITAL, LLC's current position in ANRO?
As of Q2 2026, ARMISTICE CAPITAL, LLC holds 864.00K shares of ANRO (ALTO NEUROSCIENCE INC COM SHS), valued at $22.80M, representing 0.30% of its reported portfolio and ranking #49.
Has ARMISTICE CAPITAL, LLC been buying or selling ANRO?
In the latest 13F filing (Q2 2026), ARMISTICE CAPITAL, LLC reduced its position in ANRO. The position peaked in Q4 2025 at 1.54M shares.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, PERCEPTIVE ADVISORS LLC, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.